• Citer

Expression, prognostic and predictive impact of VEGF and bFGF in non-small cell lung cancer.

par Farhat, Fadi Sami;Tfayli, Arafat;Fakhruddin, Najla;Mahfouz, Rami;Otrock, Zaher K;Alameddine, Raafat S;Awada, Ahmad ;Shamseddine, Ali I
Référence Critical reviews in oncology/hematology, 84, 2, page (149-160)
Publication Publié, 2012-11

Article révisé par les pairs

• Accès en ligne
• Détails
• Contenu
• Statistiques

Résumé :

Despite major advances in cancer therapeutics, the prognosis for lung cancer patients is still poor and the median survival for patients presenting with advanced non-small cell lung cancer (NSCLC) is only 8-10 months. Angiogenesis is an important biological process and a relatively early event during lung cancer pathogenesis. Anti-angiogenic agents are used in treating patients with NSCLC, and their molecular biomarkers are also being assessed to predict response. A better understanding of the biology of angiogenesis in NSCLC may reveal new targets for treating this malignancy. In this article, we review the expression and prognostic impact of the angiogenic growth factors, vascular endothelial growth factor and basic fibroblast growth factor, in NSCLC.